About Neuralink
Neuralink is a neurotechnology company developing brain-computer interfaces (BCIs) designed to connect neural activity with external devices. Its investigational implant technology aims to help people with severe paralysis interact with computers and other digital tools using brain signals.
Founded in 2016, Neuralink has pursued advances in implantable electronics, robotic surgery, neural signal processing, and software. Its first-in-human research has focused on evaluating the safety and functionality of an investigational brain-computer interface. These devices remain subject to clinical investigation and regulatory requirements.
As a privately held company, Neuralink does not trade on a public exchange. Interest in Neuralink pre-IPO stock has grown alongside developments in the broader brain-computer interface sector, although private share transactions may be restricted and difficult to complete.
Neuralink Funding and Valuation
Neuralink has raised private capital to support its research, clinical programs, and technology development. Funding-round valuations are snapshots negotiated between investors and the company, not continuously quoted share prices.
| Funding Event | Reported Timing | Reported Amount | Notes |
|---|---|---|---|
| Series E | June 2025 | $650M | Company-announced financing |
| Series D | August 2023 | $280M | Company-announced financing |
| Series C | July 2021 | $205M | Company-announced financing |
Selected historical financing events. Amounts are based on reported announcements and are not a complete capitalization history. No current Neuralink stock price or valuation is represented here.
Can You Buy or Sell Neuralink Stock Before an IPO?
Because Neuralink is private, its shares cannot be purchased through a conventional public stock exchange. Certain existing shareholders may seek liquidity, and eligible investors may explore opportunities in private secondary markets. However, transactions depend on available counterparties, company transfer restrictions, applicable securities laws, and required approvals.
For financial professionals evaluating opportunities to buy or sell Neuralink stock, FNEX’s institutional Pre-IPO Market provides a channel to explore private-company secondary transactions, including access to verified bids and offers where available. A Neuralink transaction is not guaranteed, and this page does not indicate a current listing or available inventory.
How Private Share Transactions Typically Work
1. Confirm eligibility
Private securities transactions may be limited to qualified institutional or accredited participants, depending on the transaction.
2. Evaluate availability
Shareholders and prospective buyers assess whether an eligible block of shares and a suitable counterparty are available.
3. Review transaction restrictions
Transfers may require company consent, compliance with rights of first refusal, and completion of legal documentation.
4. Complete diligence and settlement
Parties review pricing, share class, fees, risks, and settlement terms before proceeding.
Neuralink Company Details
Neuralink Stock FAQs
Is Neuralink publicly traded?
What is Neuralink’s stock ticker?
How can investors buy Neuralink pre-IPO shares?
Can existing shareholders sell Neuralink stock?
What is Neuralink’s current stock price?
When will Neuralink go public?
Explore Private-Company Secondary Markets
FNEX connects qualified financial professionals with an institutional network for private-company secondary transactions. Explore verified bids and offers, where available, across late-stage private companies.
Learn About the FNEX Pre-IPO MarketFor informational purposes only. This material is not an offer to sell or a solicitation of an offer to buy securities, including Neuralink securities. FNEX is not affiliated with Neuralink. Mention of Neuralink does not imply that FNEX has Neuralink shares available for purchase or sale.
Private securities are illiquid and speculative and may involve substantial or total loss of capital. Eligibility, availability, transfer approvals, pricing, and transaction terms vary. Historical funding data are not current market quotations or guarantees of future performance. Any transaction is subject to applicable law, suitability and eligibility requirements, and relevant offering documentation.
